🇺🇸 FDA
Pipeline program

Bupropion

NIDA-16427-5

Approved small_molecule completed

Quick answer

Bupropion for Tobacco Use Cessation is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tobacco Use Cessation
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials